Citrus bioflavonoids for weight management Cifrus Clin Pract. Burki, T. Further studies Prenatal vitamins warranted to mnaagement the long-term effects of Sinetrol-XPur. Four flavonoid compounds from phyllostachys edulis leaf extract retard the digestion of starch and its working mechanisms.

Video

Avoid These 7 Foods That Can Kill You

Citrus bioflavonoids for weight management -

Although most of the assays have been done with in vitro models of digestion, it seems that the food matrices protect bioactive compounds from intestinal degradation.

Understanding how dietary flavonoids interact with the food matrix will aid in developing food products with higher positive health impacts for the consumer Furthermore, the absorption of flavonoids in the human body is dose- and type-dependent, affecting their bioavailability and pharmacokinetics.

They show a low absorption rate and limited stability when they pass through the intestinal tract, where the microbiome may contribute to their absorption. Once absorbed, they enter the portal circulation, which brings structural changes in the molecules that alter their properties.

Therefore, it is essential to consider how intestinal digestion and microbiota affect their uptake, metabolization, and bioavailability Some studies also show that flavonoids enhance the production of glucagon-like-peptide GLP-1 production, which positively affects gut bacteria More thorough investigations are needed to determine this point because the gut microbiota significantly impacts the overall physicochemical and pharmacokinetic properties of flavonoids In addition to metabolism, membrane transporters, primarily efflux transporters, have long been known to influence drug absorption and bioavailability.

Nevertheless, much remains about how cells handle flavonoids To improve the bioavailability of flavonoids, we must overcome several development hurdles, including solubility, permeability, metabolism, excretion, uptake, and disposition.

Studies are needed to be performed to demonstrate how changes in the structure of flavonoids affect their solubility and dissolution rates and how various pharmaceutical excipients might be employed to increase dissolution rates. Methylation, acylation, glycosylation, and prenylation are common substitution patterns that afford diversity in the structure of flavonoids and modulate their properties.

Glycosylation usually modifies the metabolism and absorption of flavonoids but fetters their bioavailability. Methylation could be used to improve bioavailability, but the lack of ability to improve bioavailability other than using methylated prodrugs could impede the use of flavonoids as drugs since methylation often adversely affects the activity.

More bioavailable or extremely bioavailable formulations or derivatives are highly desirable since they will be less difficult to produce and test The pharmacokinetic characteristics of flavonoids and other natural substances are significantly improved by nanosuspension technology, and there is much room for further research in this area Nanocarriers can potentially improve flavonoid bioavailability Nanoparticles mainly include polymeric, solid-lipid nanoparticles, nanostructured lipid carriers, micelles, liposomes, nanosuspensions, and nanoemulsions.

The pharmacokinetic parameters reveal that nanosuspension enhances absorption and increases the bioavailability of flavonoids Flavonoid glycosides show improved stability and bioavailability, and the metabolic engineering technique is an efficient and promising way to glycosylate the flavonoids.

The discovery of new glycosyltransferases and the establishment of an efficient metabolic network will be important for synthesizing specific flavonoid glycosides The complexation of flavonoids with cyclodextrins is a promising approach to improving their stability, aqueous solubility, rate of dissolution, and bioavailability A combination of flavonoids with known anti-obesity drugs or other natural products could be useful in treating obesity due to the inhibition of fat accumulation and the promotion of lipodieresis Some studies demonstrate the beneficial effects of flavonoids in combination with procyanidin 20 by inducing satiety, satisfying hunger, or reducing craving urges.

Still, little is known about the effect of combining different flavonoids or combining flavonoids with known drugs. It remains vastly unexplored whether they will have synergic, additive, or antagonistic effects.

The extent to which human diets must be tailored for maximum health is unknown, but a one-diet-suits-all appears implausible. On the other hand, personal or precision nutrition necessitates a greater focus on the peculiarities of nutrient-microbe interactions AC, NM, and DB: conceptualization, supervision, project administration, and funding acquisition.

AnM, SMS, ArM, MYW, AC, and NM: literature review and resources. AnM, SMS, ArM, MYW, SG, AC, and NM: writing—original draft preparation. AC, NM, SMS, and DB: writing—review and editing. SMS, AnM, and NM: figures and tables preparations and editing.

AC: visualization. All authors contributed to the article and approved the submitted version. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Ritchie, H. Google Scholar. Obesity and overweight. Kyrou, I. Clinical problems caused by obesity. In Feingold, KR, Anawalt, B, Blackman, MR, Boyce, A, Chrousos, G, Corpas, E, et al.

Endotext [Internet]. South Dartmouth, MA: MDText. com, Inc. Hecker, J, Freijer, K, Hiligsmann, M, and Evers, S. Burden of disease study of overweight and obesity; the societal impact in terms of cost-of-illness and health-related quality of life. BMC Public Health. doi: CrossRef Full Text Google Scholar.

Health effects of overweight and obesity. html Accessed December 28, Manna, P, and Jain, SK. Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: causes and therapeutic strategies.

Metab Syndr Relat Disord. Azab, AE, Adwas, AA, Elsayed, ASI, Adwas, AA, and Quwaydir, FA. Oxidative stress and antioxidant mechanisms in human body. J Appl Biotechnol Bioeng. Irshad, M, and Chaudhuri, PS. Oxidant-antioxidant system: role and significance in human body. Indian J Exp Biol.

PubMed Abstract Google Scholar. Sharifi-Rad, M, Anil Kumar, N, Zucca, P, Varoni, EM, Dini, L, Panzarini, E, et al. Lifestyle, oxidative stress, and antioxidants: Back and forth in the pathophysiology of chronic diseases.

Front Physiol. PubMed Abstract CrossRef Full Text Google Scholar. Calzadilla, P, Gómez-Serrano, M, García-Santos, E, Schiappacasse, A, Abalde, Y, Calvo, JC, et al.

N-acetylcysteine affects obesity-related protein expression in 3T3-L1 adipocytes. Redox Rep. Dludla, P, Mazibuko-Mbeje, SE, Nyambuya, TM, Mxinwa, V, Tiano, L, Marcheggiani, F, et al. The beneficial effects of N-acetyl cysteine NAC against obesity associated complications: a systematic review of pre-clinical studies.

Pharmacol Res. Lin, X, and Li, H. Obesity: epidemiology, pathophysiology, and therapeutics. Front Endocrinol. Burki, T. European Commission classifies obesity as a chronic disease. Lancet Diabetes Endocrinol.

Müller, TD, Blüher, M, Tschöp, MH, and DiMarchi, RD. Anti-obesity drug discovery: advances and challenges. Nat Rev Drug Discov.

Apovian, CM, Aronne, LJ, Bessesen, DH, McDonnell, ME, Murad, MH, Pagotto, U, et al. Pharmacological management of obesity: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. The Asia-Pacific perspective: Redefining obesity and its treatment. Sydney, Australia: Health Communications Australia Pty Limit Son, JW, and Kim, S.

Comprehensive review of current and upcoming anti-obesity drugs. Diabetes Metab J. Heymsfield, SB, and Wadden, TA. Mechanisms, pathophysiology, and Management of Obesity. N Engl J Med. Hauner, H, Hastreiter, L, Werdier, D, Chen-Stute, A, Scholze, J, and Blüher, M. Efficacy and safety of Cathine nor-pseudoephedrine in the treatment of obesity: a randomized dose-finding study.

Obes Facts. Song, D, Cheng, L, Zhang, X, Wu, Z, and Zheng, X. The modulatory effect and the mechanism of flavonoids on obesity. J Food Biochem. Sjostrom, L, Rissanen, A, Andersen, T, Boldrin, M, Golay, A, Koppeschaar, HP, et al.

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Huang, R, Zhang, Y, Shen, S, Zhi, Z, Cheng, H, Chen, S, et al. Antioxidant and pancreatic lipase inhibitory effects of flavonoids from different citrus peel extracts: an in vitro study.

Food Chem. Capuani, B, Pacifici, F, Della-Morte, D, and Lauro, D. Glucagon like peptide 1 and MicroRNA in metabolic diseases: focusing on GLP1 action on miRNAs.

de Mello, AH, Prá, M, Cardoso, LC, de Bona Schraiber, R, and Rezin, GT. Incretin-based therapies for obesity treatment. Davies, M, Færch, L, Jeppesen, OK, Pakseresht, A, Pedersen, SD, Perreault, L, et al. Efficacy and safety of Semaglutide 2. J Endocr Soc. Wilding, JPH, Batterham, RL, Calanna, S, Davies, M, van Gaal, LF, Lingvay, I, et al.

Once-weekly Semaglutide in adults with overweight or obesity. Glucagon-like peptide 1 GLP Mol Metab. Day, JW, Ottaway, N, Patterson, JT, Gelfanov, V, Smiley, D, Gidda, J, et al.

A new glucagon and GLP-1 co-agonist eliminates obesity in rodents. Nat Chem Biol. Zhang, Y, Proenca, R, Maffei, M, Barone, M, Leopold, L, and Friedman, JM. Positional cloning of the mouse obese gene and its human homologue. Ravussin, E, Smith, SR, Mitchell, JA, Shringarpure, R, Shan, K, Maier, H, et al.

Liu, J, Lee, J, Hernandez, MAS, Mazitschek, R, and Ozcan, U. Treatment of obesity with celastrol. Lee, J, Liu, J, Feng, X, Hernández, MAS, Mucka, P, Ibi, D, et al.

Withaferin a is a leptin sensitizer with strong antidiabetic properties in mice. Nat Med. Tschop, M, Smiley, DL, and Heiman, ML. Ghrelin induces adiposity in rodents. Grundlingh, J, Dargan, PI, El-Zanfaly, M, and Wood, DM. J Med Toxicol. Mullican, SE, Lin-Schmidt, X, Chin, CN, Chavez, JA, Furman, JL, Armstrong, AA, et al.

GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates. Tian, C, Liu, X, Chang, Y, Wang, R, Lv, T, Cui, C, et al.

Investigation of the anti-inflammatory and antioxidant activities of luteolin, kaempferol, apigenin and quercetin. S Afr J Bot. Xiao, JB, Huo, JL, Yang, F, and Chen, XQ. J Agric Food Chem. Hirayama, F, Lee, AH, Binns, CW, Hiramatsu, N, Mori, M, and Nishimura, K.

Dietary intake of isoflavones and polyunsaturated fatty acids associated with lung function, breathlessness and the prevalence of chronic obstructive pulmonary disease: possible protective effect of traditional Japanese diet.

Mol Nutr Food Res. Marrelli, M, Loizzo, MR, Nicoletti, M, Menichini, F, and Conforti, F. In vitro investigation of the potential health benefits of wild Mediterranean dietary plants as anti-obesity agents with α-amylase and pancreatic lipase inhibitory activities. J Sci Food Agric.

Oteiza, PI, Fraga, CG, Mills, DA, and Taft, DH. Flavonoids and the gastrointestinal tract: local and systemic effects.

Mol Asp Med. Irondi, EA, Ajani, EO, Aliyu, OM, Olatoye, KK, Abdulameed, HT, and Ogbebor, OF. Bioactive components, enzymes inhibitory and antioxidant activities of biofortified yellow maize Zea mays l. and cowpea vigna unguiculata l. walp composite biscuits. Ann Univ Dunarea Jos Galati Fascicle VI: Food Technol.

Sellami, M, Louati, H, Kamoun, J, Kchaou, A, Damak, M, and Gargouri, Y. Inhibition of pancreatic lipase and amylase by extracts of different spices and plants.

Int J Food Sci Nutr. Martinez-Gonzalez, AI, Díaz-Sánchez, G, de la Rosa, LA, Bustos-Jaimes, I, and Alvarez-Parrilla, E. Inhibition of α-amylase by flavonoids: structure activity relationship SAR.

Spectrochim Acta A Mol Biomol Spectrosc. El-shiekh, RA, Al-Mahdy, DA, Hifnawy, MS, and Abdel-Sattar, EA. In-vitro screening of selected traditional medicinal plants for their anti-obesity and anti-oxidant activities. Laya, A, Koubala, BB, and Negi, PS.

Antidiabetic α-amylase and α-glucosidase and anti-obesity lipase inhibitory activities of edible cassava Manihot esculenta Crantz as measured by in vitro gastrointestinal digestion: effects of phenolics and harvested time.

Int J Food Prop. Yang, JP, He, H, and Lu, YH. Four flavonoid compounds from phyllostachys edulis leaf extract retard the digestion of starch and its working mechanisms. Chunhe, G, Zhang, H, Putri, CY, and Ng, K. Evaluation of α-amylase and α-glucosidase inhibitory activity of flavonoids.

Int J Food Nutr Sci. Tadera, K, Minami, Y, Takamatsu, K, and Matsuoka, T. Inhibition of alpha-glucosidase and alpha-amylase by flavonoids. J Nutr Sci Vitaminol Tokyo. Azuma, T, Kayano, SI, Matsumura, Y, Konishi, Y, Tanaka, Y, and Kikuzaki, H.

Antimutagenic and α-glucosidase inhibitory effects of constituents from Kaempferia parviflora. Barber, E, Houghton, MJ, and Williamson, G. Flavonoids as human intestinal α-glucosidase inhibitors.

Proença, C, Freitas, M, Ribeiro, D, Oliveira, EFT, Sousa, JLC, Tomé, SM, et al. α-Glucosidase inhibition by flavonoids: an in vitro and in silico structure—activity relationship study. J Enzyme Inhib Med Chem. Williams, LK, Li, C, Withers, SG, and Brayer, GD.

Order and disorder: differential structural impacts of myricetin and ethyl caffeate on human amylase, an antidiabetic target. J Med Chem. Liu, TT, Liu, XT, Chen, QX, and Shi, Y. Lipase inhibitors for obesity: a review. Biomed Pharmacother. Rajan, L, Palaniswamy, D, and Mohankumar, SK.

Targeting obesity with plant-derived pancreatic lipase inhibitors: a comprehensive review. Zhou, JF, Wang, WJ, Yin, ZP, Zheng, GD, Chen, JG, Li, JE, et al. Quercetin is a promising pancreatic lipase inhibitor in reducing fat absorption in vivo.

Food Biosci. Martinez-Gonzalez, AI, Alvarez-Parrilla, E, Díaz-Sánchez, ÁG, de la Rosa, LA, Núñez-Gastélum, JA, Vazquez-Flores, AA, et al. In vitro inhibition of pancreatic lipase by polyphenols: a kinetic, fluorescence spectroscopy and molecular docking study.

Food Technol Biotechnol. Trott, O, and Olson, AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. van de Laar, FA, Lucassen, PL, Akkermans, RP, van de Lisdonk, EH, Rutten, GE, and van Weel, C.

α-Glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis. Diabetes Care. Mueckler, M, and Thorens, B. The SLC2 GLUT family of membrane transporters.

Goto, T, Horita, M, Nagai, H, Nagatomo, A, Nishida, N, Matsuura, Y, et al. Tiliroside, a glycosidic flavonoid, inhibits carbohydrate digestion and glucose absorption in the gastrointestinal tract. Johnston, K, Sharp, P, Clifford, M, and Morgan, L. Dietary polyphenols decrease glucose uptake by human intestinal Caco-2 cells.

FEBS Lett. Slavic, K, Derbyshire, ET, Naftalin, RJ, Krishna, S, and Staines, HM. Comparison of effects of green tea catechins on apicomplexan hexose transporters and mammalian orthologues. Mol Biochem Parasitol. Gauer, JS, Tumova, S, Lippiat, JD, Kerimi, A, and Williamson, G.

Differential patterns of inhibition of the sugar transporters GLUT2, GLUT5 and GLUT7 by flavonoids. Biochem Pharmacol. Singla, P. Metabolic effects of obesity: a review. World J Diabetes. Czech, MP. Insulin action and resistance in obesity and type 2 diabetes.

Martín, MÁ, and Ramos, S. Dietary flavonoids and insulin signaling in diabetes and obesity. Carvalho, E, Kotani, K, Peroni, OD, and Kahn, BB. Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle.

Am J Physiol Endocrinol Metab. Abel, ED, Peroni, O, Kim, JK, Kim, YB, Boss, O, Hadro, E, et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Shepherd, PR, Gnudi, L, Tozzo, E, Yang, H, Leach, F, and Kahn, BB.

Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem. Pessler-Cohen, D, Pekala, PH, Kovsan, J, Bloch-Damti, A, Rudich, A, and Bashan, N.

Arch Physiol Biochem. Ma, J, Nakagawa, Y, Kojima, I, and Shibata, H. Prolonged insulin stimulation Down-regulates GLUT4 through oxidative stress-mediated Retromer inhibition by a protein kinase CK2-dependent mechanism in 3T3-L1 adipocytes.

Feingold, KR In: KR Feingold, B Anawalt, and MR Blackman, editors. Obesity and dyslipidemia : Endotext Stadler, JT, and Marsche, G. Obesity-related changes in high-density lipoprotein metabolism and function.

Int J Mol Sci. Klop, B, Elte, JW, and Cabezas, MC. Dyslipidemia in obesity: mechanisms and potential targets. Yu, YH, and Ginsberg, HN. Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue.

Circ Res. Souza, SC, Palmer, HJ, Kang, YH, Yamamoto, MT, Muliro, K, and Eric Paulson, K. TNF-alpha induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3T3-L1 adipocytes.

J Cell Biochem. van Hall, G, Steensberg, A, Sacchetti, M, Fischer, C, Keller, C, and Schjerling, P. Interleukin-6 stimulates lipolysis and fat oxidation in humans. Arnold, N. Lipid peroxidation as a link between unhealthy diets and the metabolic syndrome.

Pınar Ed. Davì, G, Guagnano, MT, Ciabattoni, G, Basili, S, Falco, A, and Marinopiccoli, M. Platelet activation in obese WomenRole of inflammation and oxidant stress. Olusi, SO. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans.

Int J Obes. Guillet, C, Masgrau, A, and Boirie, Y. Is protein metabolism changed with obesity? Curr Opin Clin Nutr Metab Care.

Katsanos, CS, and Mandarino, LJ. Protein metabolism in human obesity: a shift in focus from whole-body to skeletal muscle. Anderson, SR, Gilge, DA, Steiber, AL, and Previs, SF. Diet-induced obesity alters protein synthesis: tissue-specific effects in fasted versus fed mice.

Greenhaff, PL, Karagounis, LG, Peirce, N, Simpson, EJ, Hazell, M, Layfield, R, et al. Disassociation between the effects of amino acids and insulin on signaling, ubiquitin ligases, and protein turnover in human muscle. Drummond, MJ, Bell, JA, Fujita, S, Dreyer, HC, Glynn, EL, Volpi, E, et al.

Clin Nutr. Pasiakos, SM, Vislocky, LM, Carbone, JW, Altieri, N, Konopelski, K, Freake, HC, et al. Acute energy deprivation affects skeletal muscle protein synthesis and associated intracellular signaling proteins in physically active adults.

J Nutr. Zanchi, NE, and Lancha, AH Jr. Eur J Appl Physiol. Baron, AD, Tarshoby, M, Hook, G, Lazaridis, EN, Cronin, J, Johnson, A, et al. Interaction between insulin sensitivity and muscle perfusion on glucose uptake in human skeletal muscle: evidence for capillary recruitment. Clerk, LH, Vincent, MA, Jahn, LA, Liu, Z, Lindner, JR, and Barrett, EJ.

Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle. Tack, CJ, Ong, MK, Lutterman, JA, and Smits, P. Effects of troglitazone. Beals, JW, Burd, NA, Moore, DR, and van Vliet, S. Obesity alters the muscle protein synthetic response to nutrition and exercise.

Front Nutr. Gentile, D, Fornai, M, Pellegrini, C, Colucci, R, Blandizzi, C, and Antonioli, L. The research was funded primarily by the Heart and Stroke Foundation of Ontario.

Materials provided by University of Western Ontario. Note: Content may be edited for style and length. Science News.

Facebook Twitter Pinterest LinkedIN Email. FULL STORY. RELATED TERMS Obesity Personalized medicine Diabetes mellitus type 2 Diabetes Diabetes mellitus type 1 Physical exercise Fruit Alzheimer's disease.

Story Source: Materials provided by University of Western Ontario. Cite This Page : MLA APA Chicago University of Western Ontario.

ScienceDaily, 14 July University of Western Ontario. Citrus-derived Flavonoid Prevents Obesity, Study Suggests. Retrieved February 14, from www. htm accessed February 14, Explore More. Sugar Disrupts Microbiome, Eliminates Protection Against Obesity and Diabetes. The findings suggest that diet Researchers Identify Potential New Treatment for Metabolic Syndrome.

Along with colleagues from Gachon University and Sungkyunkwan University in Korea, the team enrolled 86 overweight or obese South Korean subjects in the randomised, double-blind, placebo-control trial. Participants took either two Sinetrol-XPur tablets milligrams mg per tablet or two placebo tablets once a day for weeks.

Along with the decreases in body weight and reduction in BMI, the team also found a reduction in waist circumference However, the changes between the groups were not statistically significant.

Taken together, we suggested that Sinetrol-XPur could act as a potential antiobesity compound. Further studies are warranted to investigate the long-term effects of Sinetrol-XPur.

Delving deeper into the Sinetrol-XPur possible mechanisms of action, the team cites studies that reveal the inhibitory action of flavonoids on the activity of an enzyme group cAMP-phosphodiesterase leading to rising cellular levels of cAMP, a messenger involved in biological processes.

Elevated cAMP levels stimulate fat breakdown by activating PKA, a signalling molecule. This then goes on to activates the CREB protein that leads to the increased expression of another protein UCP UCP-2 plays an important role in body weight regulation, energy stability, and thermoregulation in humans.

Hence, these flavonoids could plausibly be used in the management of obesity.

Citrus fruits are widely consumed Cigrus their nutritional ror health benefits. Managemebt belong to Flexible resupply scheduling Rutaceae weifht have many varieties, such as sweet Natural energy boosters for women Citrus sinensiswhich is the most bioflavojoids. They Metformin and polycystic ovary syndrome contain bioactive components, which may modulate energy metabolism and lipid oxidation through various mechanisms. These mechanisms include stimulating β3-adrenergic receptors, increasing mitochondrial biogenesis and thermogenesis, activating AMP kinase and peroxisome proliferator-activated receptor-gamma coactivator-1α pathways, inhibiting lipogenesis and lipid accumulation, and inducing browning of white adipose tissue. This review summarizes the mechanisms and outcomes of citrus fruits and their metabolites on energy metabolism and body weight in different experimental models. Citrus bioflavonoid supplements are made from Flexible resupply scheduling fruits. Citrus Aeight supplements are vioflavonoids commonly used to increase metabolism. Although citrus bioflavonoid supplements alone will not help you lose weight, they can give you the boost you need with proper diet and exercise. Citrus bioflavonoid supplements can benefit your overall health and be extremely beneficial to athletes and bodybuilders. If you feel good, you can train longer and harder. Since citrus bioflavonoid supplements are a natural supplement, the side effects are minimal.